(Stroke. 2000;31:2971.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Departments of Neurology (K.F., B.H., M.F., A.R., S.K., M.H.), Internal Medicine (S.R.), Clinical Chemistry (T.B.), Anesthesiology (J.S., M.W.-W.), and Neurosurgery (S.S., P.H., P.V., J.B., L.S., P.S.), Clinic Mannheim, University of Heidelberg, Heidelberg, Germany.
Correspondence to Klaus Faßbender, MD, Department of Neurology, Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer, 68135 Mannheim, FRG. E-mail Fass{at}neuro.ma.uni-heidelberg.de
Background and PurposeThe most potent vasoconstrictor known, endothelin-1, is currently considered to mediate cerebral vasospasm in subarachnoid hemorrhage (SAH), which can cause delayed cerebral ischemia. In our study, we performed clinical and in vitro experiments to investigate the origin and the mechanisms of the secretion of endothelin-1 in SAH.
MethodsEndothelin-1 and markers of inflammatory host response
(interleukin [IL]-1ß, IL-6, and tumor necrosis factor-
) were
comparatively quantified in the cerebrospinal fluid (CSF) of SAH
patients and control subjects, and concentrations were related to
clinical characteristics. Furthermore, mononuclear leukocytes isolated
from the CSF of SAH patients and control subjects were analyzed
regarding their mRNA expression of endothelin-1 and inflammatory
cytokines. Finally, complementary in vitro experiments were
performed to investigate whether coincubation of blood and CSF can
trigger leukocytic mRNA expression and release of these factors.
ResultsActivated mononuclear leukocytes in the CSF of
SAH patients synthesize and release endothelin-1 in parallel with known
acute-phase reactants (IL-1ß, IL-6, and tumor necrosis factor-
).
Complementary in vitro experiments not only further confirmed this
leukocytic origin of endothelin-1 but also showed that aging and
subsequent hemolysis of blood is sufficient to induce such endothelin-1
production.
ConclusionsThe demonstration that endothelin-1 is produced by activated CSF mononuclear leukocytes suggests that subarachnoid inflammation may represent a therapeutic target to prevent vasospasm and delayed cerebral ischemia after SAH.
Key Words: cerebral ischemia cytokines endothelins subarachnoid hemorrhage vasospasm
This article has been cited by other articles:
![]() |
H. Yatsushige, M. Yamaguchi, C. Zhou, J. W. Calvert, and J. H. Zhang Role of c-Jun N-Terminal Kinase in Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage Stroke, July 1, 2005; 36(7): 1538 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kay, A. Petzold, M. Kerr, G. Keir, E. Thompson, and J. Nicoll Decreased Cerebrospinal Fluid Apolipoprotein E After Subarachnoid Hemorrhage: Correlation With Injury Severity and Clinical Outcome Stroke, March 1, 2003; 34(3): 637 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.J.M. Frijns and L.J. Kappelle Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease Stroke, August 1, 2002; 33(8): 2115 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tosaka, F. Okajima, Y. Hashiba, N. Saito, T. Nagano, T. Watanabe, T. Kimura, and T. Sasaki Sphingosine 1-Phosphate Contracts Canine Basilar Arteries In Vitro and In Vivo: Possible Role in Pathogenesis of Cerebral Vasospasm Stroke, December 1, 2001; 32(12): 2913 - 2919. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |